These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 2517125)

  • 1. Impaired T-cell activation in patients with systemic lupus erythematosus.
    Sierakowski S; Kucharz EJ; Lightfoot RW; Goodwin JS
    J Clin Immunol; 1989 Nov; 9(6):469-76. PubMed ID: 2517125
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phorbol myristate acetate (PMA) reverses inhibition of interleukin-2 production by T lymphocytes of patients with systemic lupus erythematosus.
    Sierakowski S; Kucharz EJ
    Med Interne; 1988; 26(1):67-73. PubMed ID: 3261032
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Abnormalities in CD69 expression, cytosolic pH and Ca2+ during activation of lymphocytes from patients with systemic lupus erythematosus.
    Portales-Pérez D; González-Amaro R; Abud-Mendoza C; Sánchez-Armáss S
    Lupus; 1997; 6(1):48-56. PubMed ID: 9116719
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deficient phytohemagglutinin-induced interleukin-2 activity in patients with inactive systemic lupus erythematosus is correctable by the addition of phorbol myristate acetate.
    Murakawa Y; Sakane T
    Arthritis Rheum; 1988 Jul; 31(7):826-33. PubMed ID: 3260781
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of phorbol myristate acetate (PMA) and ionophore A23187 on interleukin-2 levels and proliferation of activated T lymphocytes from patients with lepromatous leprosy.
    Alfaro-Bustamante F; Ramirez-Flores G; Gonzalez-Mendoza A; Islas-Rodriguez A; Fafutis-Morris M
    Int J Lepr Other Mycobact Dis; 1997 Mar; 65(1):73-9. PubMed ID: 9207756
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Further characterization of interleukin-2 production by lymphocytes of patients with systemic lupus erythematosus.
    Linker-Israeli M; Quismorio FP; Horwitz DA
    J Rheumatol; 1988 Aug; 15(8):1216-22. PubMed ID: 2972835
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of T lymphocyte subpopulations responsible for deficient interleukin 2 activity in patients with systemic lupus erythematosus.
    Murakawa Y; Takada S; Ueda Y; Suzuki N; Hoshino T; Sakane T
    J Immunol; 1985 Jan; 134(1):187-95. PubMed ID: 3917275
    [TBL] [Abstract][Full Text] [Related]  

  • 8. T lymphocytes from patients with systemic lupus erythematosus show increased response to interleukin-2 after costimulation with OKT3 monoclonal antibody and phorbol esters.
    Blasini AM; Stekman IL; Gonzalez F; Tositti ML; Rodriguez MA
    Clin Immunol Immunopathol; 1994 Jan; 70(1):66-72. PubMed ID: 8261671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decreased production of and response to interleukin-2 by cultured lymphocytes from patients with systemic lupus erythematosus.
    Alcocer-Varela J; Alarcón-Segovia D
    J Clin Invest; 1982 Jun; 69(6):1388-92. PubMed ID: 6979554
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of phorbol myristate acetate on T cell colony formation, interleukin-2 (IL-2) receptor expression and IL-2 production by cells from patients at all stages of HIV infection.
    Allouche M; Lunardi-Iskandar Y; Varela-Millot C; Itzhaki M; Cornuet P; Meyer P; Jasmin C; Georgoulias V
    Clin Exp Immunol; 1990 Aug; 81(2):200-6. PubMed ID: 1696861
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A defect in the protein kinase C system in T cells from patients with systemic lupus erythematosus.
    Tada Y; Nagasawa K; Yamauchi Y; Tsukamoto H; Niho Y
    Clin Immunol Immunopathol; 1991 Aug; 60(2):220-31. PubMed ID: 2070568
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Defective expression of p70/75 interleukin 2 receptor in T cells from patients with systemic lupus erythematosus: a possible defect in the process of increased intracellular calcium leading to p70/75 expression.
    Saiki O; Tanaka T; Kishimoto S
    J Rheumatol; 1990 Oct; 17(10):1303-7. PubMed ID: 2254888
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Responsiveness of systemic lupus erythematosus T cells to signals provided through LCA T200 (CD45) and T1 (CD5) antigens.
    Martorell J; Font J; Rojo I; Vilella R; Ingelmo M; Vives J
    Clin Exp Immunol; 1989 Nov; 78(2):172-6. PubMed ID: 12412744
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of IL 1-dependent and IL 1-independent T cell lines by calcium ionophore and phorbol ester.
    Zlotnik A; Daine B
    J Immunol; 1986 Feb; 136(3):1033-7. PubMed ID: 3079793
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Responsiveness of T lymphocytes from systemic lupus erythematosus to signals provided through CD26 antigen.
    Plana M; Font J; Viñas O; Martorell J; Ingelmo M; Vives J
    Clin Immunol Immunopathol; 1994 Aug; 72(2):227-32. PubMed ID: 7914157
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced CD3-mediated T lymphocyte proliferation in patients with systemic lupus erythematosus.
    Stekman IL; Blasini AM; Leon-Ponte M; Baroja ML; Abadi I; Rodriguez MA
    Arthritis Rheum; 1991 Apr; 34(4):459-67. PubMed ID: 1826426
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impaired phorbol ester and calcium ionophore induced proliferation of T cells from old humans.
    Chopra RK; Nagel JE; Chrest FJ; Adler WH
    Clin Exp Immunol; 1987 Nov; 70(2):456-62. PubMed ID: 3123107
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stimulation of AIDS lymphocytes with calcium ionophore (A23187) and phorbol ester (PMA): studies of cytoplasmic free Ca, IL-2 receptor expression, IL-2 production, and proliferation.
    Hofmann B; Moller J; Langhoff E; Jakobsen KD; Odum N; Dickmeiss E; Ryder LP; Thastrup O; Scharff O; Foder B
    Cell Immunol; 1989 Mar; 119(1):14-21. PubMed ID: 2493338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of T3 surface molecules in human T-cell activation: T3-dependent activation results in an increase in cytoplasmic free calcium.
    Weiss A; Imboden J; Shoback D; Stobo J
    Proc Natl Acad Sci U S A; 1984 Jul; 81(13):4169-73. PubMed ID: 6234599
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correction of interleukin-2 production in patients with systemic lupus erythematosus by removal of spontaneously activated suppressor cells.
    Linker-Israeli M; Bakke AC; Quismorio FP; Horwitz DA
    J Clin Invest; 1985 Feb; 75(2):762-8. PubMed ID: 3156152
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.